Cardiac PET

Cardiac PET (or cardiac positron emission tomography) is a form of diagnostic imaging in which the presence of heart disease is evaluated using a PET scanner. Intravenous injection of a radiotracer is performed as part of the scan. Commonly used radiotracers are Rubidium-82, Nitrogen-13 ammonia and Oxygen-15 water.[1]

Cardiac PET
ICD-10-PCSC23G, C23Y
OPS-301 code3-741

Cardiac Pet scan can assess both blood flow.[2] as well as metabolism accurately. In patients with blocked coronaries, Cardiac Pet scan< can influence the choice between bypass surgery and angioplasty. More importantly, it can be used to predict whether depressed heart function can improve after revascularization.

Who should go for Cardiac PET?

The requirements to perform Cardiac PET imaging include:
  • Facility: taking into consideration clinical workflow, as well as regulatory requirements such as requisite shielding from radiation exposure
  • Capital equipment: PET or PET/CT scanner
  • Radiopharmaceutical: Rubidium-82 generator system or close access to cyclotron produced isotopes such as Nitrogen-13 ammonia
  • Personnel: including specially trained physician, radiographers, radiation safety supervisors and optional nursing support
  • Operations: stress test monitoring, as well as emergency response equipment, processing and review workstations, administrative and support personnel are additional considerations

This form of diagnostic imaging has traditionally been perceived as cost-prohibitive in comparison to general nuclear medicine cardiac stress testing using single photon emission computed tomography (SPECT). However, due to significant gains in access to scanners, related to the widely accepted role of PET/CT in clinical oncology, cardiac PET is likely to become more widely available, particularly given various clinical and technical advantages that might make this a potential test of choice in the diagnosis of coronary artery/heart disease.[3]

References
  1. Ghosh, N; Rimoldi OE; Beanlands RS; Camici PG (December 2010). "Assessment of myocardial ischaemia and viability: role of positron emission tomography". European Heart Journal. 31 (24): 2984–2995. doi:10.1093/eurheartj/ehq361. PMID 20965888.
  2. "Blood Flow Parameter". ScienceDirect, The leading platform of peer-reviewed literature that helps you move your research forward. Retrieved 2020-09-10.
  3. K Nandalur, B Dwamena, A Choudhri, et al., "Diagnostic Performance of Positron Emission Tomography in the Detection of Coronary Artery Disease: A Meta-analysis" Academic Radiology, Vol 15, No 4, April 2008
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.